138 related articles for article (PubMed ID: 24166974)
1. Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-α.
Huizinga R; van Rijs W; Bajramovic JJ; Kuijf ML; Laman JD; Samsom JN; Jacobs BC
J Immunol; 2013 Dec; 191(11):5636-45. PubMed ID: 24166974
[TBL] [Abstract][Full Text] [Related]
2. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.
Kuijf ML; Samsom JN; van Rijs W; Bax M; Huizinga R; Heikema AP; van Doorn PA; van Belkum A; van Kooyk Y; Burgers PC; Luider TM; Endtz HP; Nieuwenhuis EE; Jacobs BC
J Immunol; 2010 Jul; 185(1):748-55. PubMed ID: 20525894
[TBL] [Abstract][Full Text] [Related]
3. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner.
Bax M; Kuijf ML; Heikema AP; van Rijs W; Bruijns SC; García-Vallejo JJ; Crocker PR; Jacobs BC; van Vliet SJ; van Kooyk Y
Infect Immun; 2011 Jul; 79(7):2681-9. PubMed ID: 21502591
[TBL] [Abstract][Full Text] [Related]
4. Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice.
Huizinga R; Easton AS; Donachie AM; Guthrie J; van Rijs W; Heikema A; Boon L; Samsom JN; Jacobs BC; Willison HJ; Goodyear CS
PLoS One; 2012; 7(3):e34416. PubMed ID: 22470569
[TBL] [Abstract][Full Text] [Related]
5. Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome.
Huizinga R; van den Berg B; van Rijs W; Tio-Gillen AP; Fokkink WJ; Bakker-Jonges LE; Geleijns K; Samsom JN; van Doorn PA; Laman JD; Jacobs BC
Ann Neurol; 2015 Sep; 78(3):343-54. PubMed ID: 26017721
[TBL] [Abstract][Full Text] [Related]
6. Investigation of possible cytokine induction in peripheral blood mononuclear cells by heat-stable serotypes of Campylobacter jejuni.
Chatzipanagiotou S; Michalopoulou M; Marinou I; Boufidou F; Papavasileiou E; Trikka-Graphakos E; Kabouri E; Nicolaou C; Legakis NJ
Clin Microbiol Infect; 2005 Jan; 11(1):63-5. PubMed ID: 15649306
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.
Geleijns K; Jacobs BC; Van Rijs W; Tio-Gillen AP; Laman JD; van Doorn PA
J Neuroimmunol; 2004 May; 150(1-2):132-8. PubMed ID: 15081257
[TBL] [Abstract][Full Text] [Related]
8. The role of endotoxin in infection: Helicobacter pylori and Campylobacter jejuni.
Moran AP
Subcell Biochem; 2010; 53():209-40. PubMed ID: 20593269
[TBL] [Abstract][Full Text] [Related]
9. The immunobiology of Campylobacter jejuni: Innate immunity and autoimmune diseases.
Phongsisay V
Immunobiology; 2016 Apr; 221(4):535-43. PubMed ID: 26709064
[TBL] [Abstract][Full Text] [Related]
10. Enhanced, sialoadhesin-dependent uptake of Guillain-Barre syndrome-associated Campylobacter jejuni strains by human macrophages.
Heikema AP; Koning RI; Duarte dos Santos Rico S; Rempel H; Jacobs BC; Endtz HP; van Wamel WJ; Samsom JN
Infect Immun; 2013 Jun; 81(6):2095-103. PubMed ID: 23529622
[TBL] [Abstract][Full Text] [Related]
11. Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
Brooks PT; Brakel KA; Bell JA; Bejcek CE; Gilpin T; Brudvig JM; Mansfield LS
Microbiome; 2017 Aug; 5(1):92. PubMed ID: 28789710
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
13. Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update.
Nyati KK; Nyati R
Biomed Res Int; 2013; 2013():852195. PubMed ID: 24000328
[TBL] [Abstract][Full Text] [Related]
14. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
[TBL] [Abstract][Full Text] [Related]
15. Campylobacter jejuni capsular genotypes are related to Guillain-Barré syndrome.
Heikema AP; Islam Z; Horst-Kreft D; Huizinga R; Jacobs BC; Wagenaar JA; Poly F; Guerry P; van Belkum A; Parker CT; Endtz HP
Clin Microbiol Infect; 2015 Sep; 21(9):852.e1-9. PubMed ID: 26070960
[TBL] [Abstract][Full Text] [Related]
16. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
17. TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome.
Nyati KK; Prasad KN; Rizwan A; Verma A; Paliwal VK
Arch Neurol; 2011 Apr; 68(4):445-52. PubMed ID: 21482924
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides.
Heikema AP; Bergman MP; Richards H; Crocker PR; Gilbert M; Samsom JN; van Wamel WJ; Endtz HP; van Belkum A
Infect Immun; 2010 Jul; 78(7):3237-46. PubMed ID: 20421384
[TBL] [Abstract][Full Text] [Related]
20. The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome.
Xiang SL; Zhong M; Cai FC; Deng B; Zhang XP
J Neuroimmunol; 2006 May; 174(1-2):126-32. PubMed ID: 16567003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
